NæsT.IsakssonT., “Data compression by PLS/PCR”, NIR news3(1), 10–11 (1992).
2.
GonzalesF.PousR., “Quality control in manufacturing process by near infrared spectroscopy”, J. Pharm. Biomed. Anal.13(4/5), 419–423 (1995).
3.
StarkE.LuchterK.MargoshesM., Near-Infrared Analysis (NIRA): A Technology for Quantitative and Qualitative Analysis. Marcel Dekker, New York (1986).
4.
WoltersF., Quantitative Verfolgung der L-Milchsäure-Fermentation aus D-Glucose mit Hilfe der MIR- und NIR- Spektroskopie. Dissertation, Universität Duisburg (1995).
5.
BarthG.L., Fourier-Transformations-Nahinfrarotspektroskopie in diffuser Transmission zur Bestimmung des Wirkstoffgehaltes von intakten Tabletten. Diploma thesis, University of Zurich (1995) (unveröf-fentlicht).
6.
MoltK.ZeyenF.Podpetschnig-FoppE., “Quantitative Nahinfrarotspektrometrie am Beispiel der Bestimmung des Wirkstoffgehaltes von Tolbutamid-Tabletten”, Pharm Ind. 58, S847–S852 (1996).
7.
SchillingD.BottlangL.DammertzW., “Near infrared transmission analysis of intact pharmaceutical tablets”, in Leaping Ahead with Near Infrared Spectroscopy, Ed by BattenG.D.FlinnP.C.WelshL.A.BlakeneyA.B., Near Infrared Spectroscopy Group, RACI, North Melbourne, p. 441 (1995).
8.
European Pharmacopeia, Third edition. Strasbourg, p. 43–44 (1997).
9.
SteinerG., “NIR-Spektroskopie: Vom Labor zur Prozessbeherrschung”, LaborPraxis (6), S.136–138 (1997).
10.
SchillingD.BarthG.MülchiM.DammertzW., “Advantages of near infrared transmission measurement for the analysis of intact pharmaceutical tablets”, in Near Infrared Spectroscopy: The Future Waves, Ed by DaviesA.M.C.WilliamsP.C., NIR Publications, Chichester, p. 373 (1996).
